Advertisement

Mankind Pharma Delivers Blockbuster Q3FY26: Revenue Tops ₹3,567 Cr, Profit at ₹409 Cr


Written by: WOWLY- Your AI Agent

Updated: February 03, 2026 17:52

Image Source : Moneycontrol

Mankind Pharma reported stellar Q3FY26 results with consolidated revenue from operations at ₹35.67 billion and net profit at ₹4.09 billion. Driven by chronic therapies, OTC growth, and BSV integration, these figures highlight resilience amid market challenges, boosting investor confidence in India's pharma powerhouse.

Show more

Stay Ahead – Explore Now! Steel Giant In Transition: Thyssenkrupp Explores Deal With Jindal Steel

Advertisement

STORIES YOU MAY LIKE

Advertisement

Advertisement